Intech Investment Management LLC Has $6.53 Million Stock Holdings in CVS Health Corporation $CVS

Intech Investment Management LLC boosted its stake in CVS Health Corporation (NYSE:CVS) by 50.3% in the third quarter, Holdings Channel reports. The institutional investor owned 86,564 shares of the pharmacy operator’s stock after acquiring an additional 28,953 shares during the quarter. Intech Investment Management LLC’s holdings in CVS Health were worth $6,526,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. SOA Wealth Advisors LLC. boosted its position in CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 131 shares during the last quarter. Alteri Wealth LLC raised its stake in shares of CVS Health by 3.2% during the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after purchasing an additional 131 shares in the last quarter. Holistic Financial Partners lifted its holdings in shares of CVS Health by 4.1% during the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 133 shares during the last quarter. Symmetry Partners LLC grew its stake in shares of CVS Health by 2.5% in the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after buying an additional 141 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its holdings in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Trading Up 2.2%

CVS Health stock opened at $79.74 on Friday. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The firm has a market capitalization of $101.44 billion, a PE ratio of 57.78, a PEG ratio of 0.81 and a beta of 0.50. The business’s 50-day simple moving average is $78.39 and its 200-day simple moving average is $77.13.

CVS Health (NYSE:CVS) last released its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same quarter last year, the firm posted $1.19 EPS. The company’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio is 192.75%.

Analysts Set New Price Targets

CVS has been the subject of a number of analyst reports. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Piper Sandler reiterated an “overweight” rating and issued a $101.00 price objective (up from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Barclays boosted their price target on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Finally, Mizuho raised their price objective on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.